spinoffs

A spinoff investment will likely be undervalued and it’s almost always a better option than a new issue or IPO

We continue to see attractive investment opportunities for our subscribers in top drug stocks—and that includes AbbVie Inc. Over the years, meanwhile, we’ve found that spinoffs are about as close as you can get to a sure thing in investing. It’s one key reason why we think AbbVie, itself a spinoff, has further gains ahead for investors. We recommend this stock as a Power Buy.


ABBVIE INC., $156.05, is a buy. The company (New York symbol ABBV; TSINetwork Rating: Above Average) (www.abbvie.com; Shares outstanding: 1.8 billion; Market cap: $275.7 billion; Dividend yield: 3.6%) was formed on January 3, 2013, when Abbott Laboratories (symbol ABT on New York) split into two publicly traded companies.


Since its spinoff from Abbott Laboratories, AbbVie has depended heavily on its Humira drug to drive both its sales and earnings....

New spinoffs often struggle for a period, partly because investors tend to dump their new shares. We think that’s why Kyndryl and Viatris are down since they became separate companies. Still, we believe both will eventually move higher, and we see each of them as a hold.


KYNDRYL HOLDINGS INC....

3M’s shares are down 18% since the start of 2022. The decline is partly due to legal issues involving earplugs that the company manufactured for the U.S. Army. There are now more than 280,000 lawsuits filed against 3M. Of 11 trials to date, juries have sided with the plaintiffs six times, and with 3M five times.


We feel the company will eventually settle these lawsuits....

Two of America’s oldest companies, AT&T and General Electric, are now using spinoffs to unlock value for investors. We’re confident these moves will pay off, but only AT&T is suitable for your new buying.


AT&T INC. $24 is a spinoff buy. The company (New York symbol T; Utilities sector; Shares outstanding: 7.1 billion; Market cap: $170.4 billion; Dividend yield: 8.6%; Takeover Target Rating: Medium; www.att.com) is merging its media operations (Warner Bros....

Danaher is a great example of how a company can unlock value for shareholders with spinoffs. Since 2016, the conglomerate has completed two separate spinoffs. In that time, the stock has jumped over 280% compared to just 115% for the S&P 500 Index.


More spinoffs are possible—Danaher currently has over 20 different operating companies....

We think that small caps should not make up the bulk of your diversified portfolio—but you can benefit from making the best Canadian small cap stocks a smaller part of your holdings.

Some spinoffs pay off almost immediately. High-quality firm Carrier is an example and is now up 235% since it was spun off less than two years ago. However, other spinoffs, like Vector Group and its recent Douglas Elliman spinoff, carry much more risk. Those two stocks will probably stay in a narrow range for the next year or so.


CARRIER GLOBAL CORP....

A: We generally feel that most investors should hold the bulk of their investment portfolios in conservative securities from well-established companies. This means holding a total of 15 to 25 well-established, dividend-paying stocks, chosen mainly from our “Average” or higher ratings, and spreading your holdings out across most if not all of the five main economic sectors.

However, some investors choose to add more aggressive or speculative stocks to their holdings in their pursuit of bigger, faster gains....

The term “synergy” entered common investor use during the takeover craze of the 1960s, when businesses started to expand by taking over companies in unrelated fields. This was supposed to make the combined companies grow faster than if they had stuck to their own fields.

The acquirers borrowed a term from biology to explain their rationale: this mix-rather-than-match growth strategy brought synergistic benefits....